103 related articles for article (PubMed ID: 8169776)
1. Percutaneous absorption of azone following single and multiple doses to human volunteers.
Wester RC; Melendres J; Sedik L; Maibach HI
J Pharm Sci; 1994 Feb; 83(2):124-5. PubMed ID: 8169776
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous absorption, metabolic profiling, and excretion of the penetration enhancer azone after multiple dosing of an azone-containing triamcinolone acetonide cream in humans.
Wiechers JW; Drenth BF; Jonkman JH; de Zeeuw RA
J Pharm Sci; 1990 Feb; 79(2):111-5. PubMed ID: 2324957
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous absorption and elimination of the penetration enhancer Azone in humans.
Wiechers JW; Drenth BF; Jonkman JH; de Zeeuw RA
Pharm Res; 1987 Dec; 4(6):519-23. PubMed ID: 3508567
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of skin penetration-enhancing effect by laurocapram.
Sugibayashi K; Nakayama S; Seki T; Hosoya K; Morimoto Y
J Pharm Sci; 1992 Jan; 81(1):58-64. PubMed ID: 1619571
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous absorption of hydroquinone in humans: effect of 1-dodecylazacycloheptan-2-one (azone) and the 2-ethylhexyl ester of 4-(dimethylamino)benzoic acid (Escalol 507).
Bucks DA; McMaster JR; Guy RH; Maibach HI
J Toxicol Environ Health; 1988; 24(3):279-89. PubMed ID: 3260963
[TBL] [Abstract][Full Text] [Related]
6. Malathion percutaneous absorption after repeated administration to man.
Wester RC; Maibach HI; Bucks DA; Guy RH
Toxicol Appl Pharmacol; 1983 Mar; 68(1):116-9. PubMed ID: 6845371
[TBL] [Abstract][Full Text] [Related]
7. [Effects of Azone of different concentrations on percutaneous absorption of baicalin in vitro].
L ZP; Liu Q; Lu XW
Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):1003-4. PubMed ID: 12433630
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous absorption of malathion in the guinea-pig: effect of repeated topical application.
Bucks DA; Marty JP; Maibach HI
Food Chem Toxicol; 1985 Oct; 23(10):919-22. PubMed ID: 4065766
[TBL] [Abstract][Full Text] [Related]
9. Effect of the absorption enhancer, Azone, on the transport of 5-fluorouracil across hairless rat skin.
Sugibayashi K; Hosoya K; Morimoto Y; Higuchi WI
J Pharm Pharmacol; 1985 Aug; 37(8):578-80. PubMed ID: 2864423
[TBL] [Abstract][Full Text] [Related]
10. [Study on percutaneous absorption of Xuetie Dingchuan Plaster].
Sun S; Di Liuqing ; Huang Y; Ni M; Liu J
Zhong Yao Cai; 2005 Nov; 28(11):1026-9. PubMed ID: 16514894
[TBL] [Abstract][Full Text] [Related]
11. Enhanced percutaneous penetration with 1-dodecylazacycloheptan-2-one.
Stoughton RB
Arch Dermatol; 1982 Jul; 118(7):474-7. PubMed ID: 7092271
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new penetration enhancer 1-[2-(decylthio)ethyl]azacyclopentan-2-one (HPE-101).
Yano T; Higo N; Furukawa K; Tsuji M; Noda K; Otagiri M
J Pharmacobiodyn; 1992 Sep; 15(9):527-33. PubMed ID: 1287186
[TBL] [Abstract][Full Text] [Related]
13. Disposition and metabolic profiling of the penetration enhancer Azone. I. In vitro studies: urinary profiles of hamster, rat, monkey, and man.
Wiechers JW; Drenth BF; Adolfsen FA; Prins L; de Zeeuw RA
Pharm Res; 1990 May; 7(5):496-9. PubMed ID: 2367317
[TBL] [Abstract][Full Text] [Related]
14. Effects of penetration enhancers on percutaneous absorption of nifedipine. Comparison between Deet and Azone.
Kondo S; Mizuno T; Sugimoto I
J Pharmacobiodyn; 1988 Feb; 11(2):88-94. PubMed ID: 3379568
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of hydrocortisone permeation of human and hairless mouse skin by 1-dodecylazacycloheptan-2-one.
Hou SY; Flynn GL
J Invest Dermatol; 1989 Dec; 93(6):774-9. PubMed ID: 2584743
[TBL] [Abstract][Full Text] [Related]
16. Human in vivo percutaneous absorption of pyrethrin and piperonyl butoxide.
Wester RC; Bucks DA; Maibach HI
Food Chem Toxicol; 1994 Jan; 32(1):51-3. PubMed ID: 8132164
[TBL] [Abstract][Full Text] [Related]
17. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 5th communication: factors affecting percutaneous absorption in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Okamura Y; Kashiwazaki K; Takahashi N
Arzneimittelforschung; 1997 Mar; 47(3):270-5. PubMed ID: 9105545
[TBL] [Abstract][Full Text] [Related]
18. Design of Ionic Liquid Formulations with Azone-Mimic Structures for Enhanced Drug Skin Permeation.
Oshizaka T; Yamamoto A; Tanaka H; Takeuchi I; Mori K; Sugibayashi K
J Pharm Sci; 2024 May; 113(5):1299-1305. PubMed ID: 38103688
[TBL] [Abstract][Full Text] [Related]
19. Enhanced skin permeation of papaverine by a medium chain glyceride.
Okumura M; Nakamori Y; Sugibayashi K; Morimoto Y
Drug Des Deliv; 1991 Apr; 7(2):147-57. PubMed ID: 1910439
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous and systemic disposition of hexamethylene lauramide and its penetration enhancement effect on hydrocortisone in a rat sandwich skin-flap model.
Tang-Liu DD; Neff J; Zolezio H; Sandri R
Pharm Res; 1988 Aug; 5(8):477-81. PubMed ID: 3244654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
